EFFECTS OF BIBP3226 AND BIBP3435 ON CYTOSOLIC CALCIUM IN NEUROPEPTIDE Y Y₁ RECEPTOR-TRANSFECTED CHINESE HAMSTER OVARY CELLS AND WILD TYPE CHO-K1 CELLS

REFERENCES

• Takemoto K., Mutt V. Isolation of Two Novel Candidate Hormones Using a Chemical Method for Finding Naturally Occuring Polypeptides. Nature 1980; 285: 417–418
   PubMedGoogle Scholar
• Takemoto K., Carlquist M., Mutt V. Neuropeptide Y: A Novel Brain Peptide with Structural Similarities to Polypeptide YY and Pancreatic Polypeptide. Nature 1982; 296: 659–660
   PubMedGoogle Scholar
• Michel M. C. Receptors for Neuropeptide Y: Multiple Subtypes and Multiple Second Messengers. Trends Pharmacol. Sci. 1991; 12: 389–394
   PubMed Web of Science ®Google Scholar
• Playford R. J., Cox H. M. Peptide YY and Neuropeptide Y: Two Peptides Intimately Involved in Electrolyte Homeostasis. Trends Pharmacol. Sci. 1996; 17: 436–438
   PubMed Web of Science ®Google Scholar
• Grundemar L., Hakanson R. Neuropeptide Y Effector Systems: Perspectives for Drug Development. Trends Pharmacol. Sci. 1994; 15: 153–159
   PubMed Web of Science ®Google Scholar
• Dumont Y., Fournier A., St-Pierre S., Quirion R. Characterization of Neuropeptide Binding Sites in Rat Brain Membrane Preparations using [125I][Leu31, Pro34l Peptide YY and [125I]Peptide YY3-36 as Selective Y1 and Y2 Radioligands. J. Pharmacol Exp. Ther. 1995; 272: 673–680
   PubMed Web of Science ®Google Scholar
• Jacques D., Cadieux A., Dumont Y., Quirion R. Apparent Affinity and Potency of BIBP3226, a Non-Peptide Neuropeptide Y Receptor Antagonist, on Purported Neuropeptide Y Y1, Y2 and Y3 Receptors. Eur. J. Pharmacol. 1995; 278: R3–R5
   Google Scholar
• Skeikh S. P., Hakanson R., Schwartz T. W. Y1 and Y2 Receptors for Neuropeptide Y. FEBS Letters 1989; 245: 209–214
   PubMedGoogle Scholar
• Wahlestedt C., Regunathan S., Reis D. J. Identification of Cultured Cells Selectively Expressing Y1-, Y2-, or Y3-type Receptors for Neuropeptide Y/Peptide YY. Life Sci. 1992; 50: PL7–PL12
   PubMedGoogle Scholar
• Inui A., Sano K., Miura M., Hirosue Y., Nakajima M., Okita M., Baba S., Kasuga M. Evidence for Further Heterogeneity of the Receptors for Neuropeptide-Y and Peptide-YY ino Tumor Cell Lines Derived from Neural Crest. Endocrinology 1992; 131: 2090–2096
   PubMedGoogle Scholar
• Stanley B. G., Leibowitz S. F. Neuropeptide Y Injected in the Paraventricular Hypothalamus: a Powerful Stimulant of Feeding Behaviour. Proc. Natl. Acad. Sci. USA 1985; 82: 3940–3493
   PubMed Web of Science ®Google Scholar
• Stanley B. G., Magdalin W., Seirafi A., Nguyen M. M., Leibowitz S. F. Evidence for NPY Mediation of Eating Produced by Food Deprivation and for a Variant of the Y1 Receptor Mediating this Peptide's Effect. Peptides 1992; 13: 581–587
   PubMed Web of Science ®Google Scholar
• Dryden S., Frankish H., Wang Q., Williams G. Neuropeptide Y and Energy Balance: One Way Ahead for the Treatment of Obesity?. Eur. J. Clin. Invest. 1994; 24: 293–308
   PubMed Web of Science ®Google Scholar
• O'Donohue T. L., Cornwall B. M., Pruss R. M., Mezey E., Kiss J. Z., Eiden L. E., Massari V. L., Tessel R. E., Pickel V. M., DiMaggio D. A. Neuropeptide Y and peptide YY Neuronal and Endocrine Systems. Peptides 1985; 6: 755–768
   PubMedGoogle Scholar
• Walker Ph., Grouzmann E., Burnier M., Waeber B. The Role of Neuropeptide Y in Cardiovascular Regulation. Trends Pharmacol. Sci. 1991; 12: 111–115
   PubMed Web of Science ®Google Scholar
• Grundemar L., Hakanson R. Multiple neuropeptide Y Receptors are Involved in Cardiovascular Regulation. Peripheral and Central Mechanisms. Gen. Pharmacol. 1993; 24: 785–796
   PubMedGoogle Scholar
• Wahlestedt C., Reis D. J. Neuropeptide Y-Related Peptides and their Receptors — are the Receptors Potential Therapeutic Drug Targets?. Annu. Rev. Pharmacol. Toxicol. 1993; 32: 309–352
   Google Scholar
• Evequoz D., Grouzmann E., Beck Sickinger A. G., Brunner H. R., Waeber B. Differential Vascular Effects of Neuropeptide Y (NPY) Selective Receptor Agonists. Experientia. 1994; 50: 936–938
   PubMedGoogle Scholar
• Rudolf K., Eberlein W., Engel W., Wieland H. A., Willim K. D., Entzeroth M., Wienen W., Beck-Sickinger A. G., Doods H. N. The First Highly Potent and Selective Non-Peptide Y Y1 Receptor Antagonist: BIBP3226. Eur. J. Pharmacol. 1994; 271: R11–R13
   PubMed Web of Science ®Google Scholar
• Serradeil-Le Gal C., Valette G., Rouby P. E., Pellet A., Villanova G., Foulon L., Neliat G., Chambon J. P., Maffrand J.-P., Le Fur G. SR120107A and SR120819A: Two Potent and Selective, Orally Effective Antagonists for NPY Y1 Receptors. Am. Soc. Neurosci Abstr. 1994; 20: 907
   Google Scholar
• Serradeil-Le Gal C., Valette G., Rouby P. E., Pellet A., Oury-Dounat F., Brossard G., Lespy L., Marthy E., Neilat G., de Cointet P., Maffrand J.-P., Le Fur G. SR120819A, an Orally Active and Selective Neuropeptide Y Y1 Receptor Antagonist. FEBS Lett. 1995; 362: 192–196
   PubMed Web of Science ®Google Scholar
• Lundberg J., Modin A., Malmström R. E. Recent Developments with Neuropeptide Y Receptor Antagonists. Trends Pharmacol. Sci. 1996; 17: 301–304
   PubMedGoogle Scholar
• Feth F., Rascher W., Michel M. C. G Protein Coupling and Signalling of Y1-like Neuropeptide Y Receptors in SK-N-MC Cells. Naunyn. Schmiedeberg's, Arch. Pharmacol. 1991; 344: 1–7
   Google Scholar
• Herzog H., Hort Y. J., Ball H. J., Hayes G., Shine J., Selbie L. A. Cloned Human NPY Receptor Couples to Two Different Second Messenger Systems. Proc. Natl. Acad. Sci. U.S.A. 1992; 89: 5794–5798
   PubMed Web of Science ®Google Scholar
• Motulsky H. J., Michell M. C. Neuropeptide Y mobilizes Ca++ and Inhibits Adenylate Cyclase in Human Erythroleukemia Cells. Am. J. Physiol. 1988; 255: E880–E885
   Google Scholar
• Shigeri Y., Fujimoto M. Two Different Signal Transductions of Neuropeptide Y1 Receptor in SK-N-MC Cells. Biochem. Biophys. Res. Commun. 1992; 187: 1565–1571
   PubMed Web of Science ®Google Scholar
• Owicki J. C., Parce J. W., Kercso R. M., Sigal G. B., Muir V. C., Venter J. C., Fraser C. M., McConnell H. M. Continuous Monitoring of Receptor-mediated Changes in the Metabolic Rates of Living Cells. Proc. Natl. Acad. Sci. USA 1990; 87: 4007–4011
   PubMed Web of Science ®Google Scholar
• McConnell H. M., Rice P., Wada G. H., Owicki J. C., Parce J. W. The Microphysiometer Biosensor. Curr. Opinion Struct. Biol. 1991; 1: 647–652
   Google Scholar
• Neve K. A., Kozlowski M. R., Rosser M. P. Dopamine D2 Receptor Stimulation of Na+/H+ Exchange Assessed by Quantification of Extracellular Acidification. J. Biol. Chem. 1992; 267: 25748–25733
   PubMedGoogle Scholar
• Chio C. L., Lajiness M. E., Huff R. M. Activation of Heterologously Expressed D3 Dopamine Receptors: Comparison with D2 Dopamine Receptors. Molecular Pharmacology. 1993; 45: 51–60
   Google Scholar
• McConnell H. M., Owicki J. R., Parce J. W., Miller D. L., Baxter G. T., Wada H. G., Pitchford S. The Cytosensor Microphysiometer: Biological Applications of Silicon Technology. Science 1992; 257: 1906–1912
   PubMed Web of Science ®Google Scholar
• Van Liefde I., Vanderheyden P., Fraeyman N., De Backer J.-P., Vauquelin G. Human Neuropeptide Y Y1 Receptors Elicit Unequal Control on the Extracellular Acidification Rate in Different Cell Lines. Eur. J. Pharmacol. 1998; 346: 87–95
   PubMedGoogle Scholar
• Grynkiewicz G., Poenie M., Tsien R. Y. A New Generation of Ca2+ Indicators with Greatly Improved Fluorescence Properties. J. Biol. Chem. 1985; 260: 3440–3450
   PubMed Web of Science ®Google Scholar
• Vanderheyden P., Van Liefde I., De Backer J.-P., Ebinger G., Vauquelin G. [3H]-BIBP3226 and [3H]-NPY Binding to Intact SK-N-MC Cells Expressing the Human Y1 Receptor. J. Receptor Signal Transduction Res. 1998; 18: 363–385
   PubMed Web of Science ®Google Scholar
• Goldman S. R., Finkbeiner M. S., Smith J. S. Endothelin Induces a Sustained rise in Intracellular Calcium in Hippocampal Astrocytes. Neurosci. Lett. 1991; 123: 4–8
   PubMedGoogle Scholar
• Yue L. T., Nambi P., Wu L. H., Feuerstein G. Endothelin Receptor Binding and Cellular Signal Transduction in Neurohybrid NG108-15 Cells. Neuroscience. 1991; 44: 215–222
   PubMedGoogle Scholar
• Chan J., Greenberg A. D. SK&F 96365, a Receptor-Mediated Calcium Entry Inhibitor, Inhibits Calcium Responses to Endothelin-1 in NG108-15 Cells. Biochem. Biophys. Res. Commun. 1991; 177: 1141–1146
   PubMed Web of Science ®Google Scholar
• Miller D. L., Olson J. C., Parce J. W., Owicki J. C. Cholinergic Stimulation of the Na+/K+ Adenosine Triphosphatase as Revealed by Microphysiometry. Biophys. J. 1993; 64: 813–823
   PubMed Web of Science ®Google Scholar
• Gordon E. A., Kohout T. A., Fishman P. H. Characterization of Functional Neuropeptide Y Receptors in a Human Neuroblastoma Cell Line. J. Neurochem. 1990; 55: 506–513
   PubMed Web of Science ®Google Scholar
• Birnbaumer L., Birnbaumer M. Signal Transduction by G Proteins (1994 edition). J. Receptor & Signal Transduction. Res. 1995; 15: 213–252
   PubMed Web of Science ®Google Scholar